v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 5,739 $ (5,545,781)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,206,363 2,238,641
(Gain) loss on disposal of property and equipment 1,376 (9,674)
Credit loss expense 141,000 294,034
Inventory obsolescence 130,822 371,957
Share-based compensation 2,524,645 2,740,343
Noncash lease expense 166,356 359,758
Share of losses from equity method investments 896,155 339,090
Back-end fee 359,067 377,490
Paid-in-kind interest 995,244
Accretion of finance liabilities 53,160 86,541
Amortization and write-off of debt issuance costs 147,083 132,821
Changes in operating assets and liabilities:    
Accounts receivable, net (700,576) 125,086
Accounts receivable – related parties 31,485
Inventory, net 358,005 (1,130,775)
Prepaid and other assets 254,547 (76,285)
Accounts payable (937,318) (42,464)
Accounts payable – related parties 1,442
Accrued royalties and expenses 898,597 317,076
Accrued bonuses and commissions (5,762,706) (579,389)
Operating lease liabilities (169,250) (361,513)
Net cash provided by (used in) operating activities (426,935) 665,127
Cash flows from investing activities:    
Purchases of property and equipment (49,052) (3,484,008)
Proceeds from disposal of property and equipment 60,000
Purchases of intangible assets (23,452)
Investment in equity securities (3,538,217)
CarePICS Acquisition (2,122,146)
Net cash used in investing activities (49,052) (9,107,823)
Cash flows from financing activities:    
Loan proceeds, net of debt issuance costs of zero in 2026 and $228,183 in 2025 12,021,817
Pay off debt assumed in CarePICS Acquisition (1,650,000)
Net settlement of equity-based awards (525,700) (692,672)
Cash payment of finance and earnout liabilities (156,000) (156,000)
Net cash provided by (used in) financing activities (681,700) 9,523,145
Net increase (decrease) in cash and cash equivalents (1,157,687) 1,080,449
Cash and cash equivalents, beginning of period 16,578,857 15,878,295
Cash and cash equivalents, end of period 15,421,170 16,958,744
Cash paid during the period for:    
Interest 3,050,346 1,516,563
Taxes 48,716 52,984
Supplemental noncash investing and financing activities:    
Non-monetary exchange to acquire intangible assets 2,084,278
Conversion of note receivable into equity method investment 1,101,478
Earnout liability generated by CarePICS Acquisition $ 1,355,603